| Unleashing the Synergistic Potential of Mango Peel Pectin and Bacillus Iranensis Synbiotics on Growth and Immune Response of Nile Tilapia |
| Paper ID : 1006-ICIAQUA |
| Authors |
|
Anisa Rilla Lubis1, Nguyen Vu Linh1, Khambou Tayyamath1, Supreya Wannavijit1, Punika Ninyamasiri1, Camilla Maria Fontana1, Sudaporn Tongsiri2, Chanagun Chitmanat2, Hien Van Doan *1 1Department of Animal and Aquatic Sciences, Chiang Mai University 2Faculty of Fisheries Technology and Aquatic Resources, Maejo University |
| Abstract |
| Purpose: This study investigates how combining pectin from fruit by-products and the probiotic Bacillus iranensis affects Nile tilapia in a biofloc system, aiming to boost growth and immune response. Finding unconventional sources for synbiotics is crucial for sustainable, cost-effective feed supplements in aquaculture. By enhancing growth and immunity in commonly farmed species like Nile tilapia, the research promotes eco-friendly aquaculture, reducing antibiotic reliance, and ensuring long-term industry sustainability. Method: Healthy Nile tilapia juveniles were divided into 4 treatment groups in 4 replicates. Throughout an 8-week period, the fish were raised in biofloc water and provided with different diets: a control diet (T1), 10 g kg-1 mango pectin (T2), 40 g kg-1 Bacillus iranensis (T3), and a synbiotics blend (T4). Growth parameters were assessed at weeks 4 and 8, with subsequent collection of skin mucus and blood serum for analysis of immune responses. Results: Synbiotics showed the best growth performance, while single pectin (T2) also improved over the control. Synbiotics increased serum and mucosal lysozyme and peroxidase activity, with added improvement from Bacillus iranensis in ACH50 activities. Conclusions: Incorporating mango pectin and Bacillus iranensis as synbiotics has shown to enhance both growth performance and immune response in Nile tilapia, suggesting their potential to boost the overall performance and wellness of the fish. |
| Keywords |
| Pectin; Bacillus iranensis; Synbiotics; Nile tilapia; Immunostimmulants. |
| Status: Abstract Accepted (Oral Presentation) |